PhaseV, a leader in software and machine learning (ML) solutions for clinical trial optimization, has announced its participation in five major industry conferences in the first half of 2025. Senior executives will present groundbreaking advancements in causal inference and adaptive ML tools, demonstrating how AI is reshaping clinical development.
“As AI-driven clinical development becomes a reality, success depends on tools tailored to the industry’s unique needs,” said Raviv Pryluk, PhD, CEO and Co-founder of PhaseV. “These conferences provide an opportunity to share our proprietary data-driven approach and expand collaborations with biotech, pharma companies, and CROs.”
Conferences and Presentations
1. Drug R&D 2025
- Date: February 10–12, 2025
- Location: Boston, MA
- Presentation Topic: AI in Clinical Trial Design
- Speaker: Raviv Pryluk, PhD, CEO and Co-founder of PhaseV
2. Adaptive Designs and Multiple Testing Procedures Workshop (ADMTP)
- Date: February 26-27, 2025
- Location: Regensburg, Germany
- Presentations:
- Exploratory Adaptive Enrichment Design with Sample Size Re-estimation
- Speaker: Elad Berkman, PhD, CTO and Co-founder of PhaseV
- Model-Guided Parameter Optimization for Complex Innovative Trial Designs
- Speaker: Raviv Pryluk, PhD, CEO and Co-founder of PhaseV
- Exploratory Adaptive Enrichment Design with Sample Size Re-estimation
3. Eastern North American Region (ENAR) 2025 Spring Meeting
- Date: March 23-26, 2025
- Location: New Orleans, LA
- Topic: Adaptive Clinical Trial Designs Using Stepwise Monte Carlo for Increased Flexibility and Robustness
- Speaker: Brad Carlin, PhD, Senior Director
4. Chief Medical Officer (CMO) Summit 360⁰
- Date: April 7-8, 2025
- Location: Boston, MA
- Topic: Reimagining Clinical Trials: How AI and ML Drive Precision, Efficiency, and Success
- Speaker: Raviv Pryluk, PhD, CEO and Co-founder of PhaseV
- Additional Presence: PhaseV will exhibit at booth 11
5. Duke Industry Statistics Symposium (DISS2025)
- Date: April 9-11, 2025
- Location: Durham, NC
- Topic: Recent Advances in Computing, Optimization, and Causal Inference for Adaptive Clinical Trials
- Speakers:
- Raviv Pryluk, PhD, CEO and Co-founder of PhaseV
- Brad Carlin, PhD, Senior Director, Data Science and Statistics at PhaseV
- Yaniv Fogel, Algo Team Lead at PhaseV
Since its inception, PhaseV has established itself as a trusted partner for over 30 global pharma and biotech companies, including seven industry leaders leveraging its ML-powered platform to enhance clinical trial efficiency. Through these key presentations, PhaseV continues to drive AI and ML innovations that transform the future of clinical development.
